Welcome CROss Alliance as a corporate member
Date: January 6, 2026
The Association for Clinical Data Management (ACDM) is delighted to welcome CROss Alliance as a new corporate member.
CROss Alliance® is a family-owned clinical CRO based in Canton Ticino, Switzerland, operating since 1996, with a high-standard FDA and Swissmedic inspected Phase I unit. The company supports hospital-based and Phase II studies through collaborations in Switzerland, Austria, and Central and Eastern Europe, delivering tailored, high-quality services across multiple therapeutic areas.
CROss Alliance joined ACDM to be part of a dynamic community and to keep up to date with training and professional development opportunities.
Members gain many benefits from membership, including:
- Access to training courses at a discounted rate
- Assign full ACDM membership to all individuals within your organisation
- Place an organisation profile, description and logo on the ACDM website
- Advertise jobs for your positions within your organisation
- Reduced price attendance at conferences and symposia
- Free attendance at Hot Topics
Find out more about becoming a corporate member here.
Explore More News

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3
As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .
Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines
The EMA has opened a public consultation on a reflection paper presenting views . . .
Read More

Welcome Instem as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .
Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance
The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .
Read More

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review
The R&D industry, especially those that are working on clinical trials, have been . . .
Read More

Welcome Algorics as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .
Read More

Consultation response on legislative proposals for clinical trials
The MHRA have published the public consultation response to the proposals to reform the . . .
Read More

New MHRA Guidance
The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .
Read More

FDA Guidance for Industry
The FDA has issued a final guidance to provide information on risk-based approaches to . . .
Read More

Guideline on computerised systems and electronic data in clinical trials
The European Medicines Agency (EMA) have published the new guidelines on computerised . . .
Read More

Welcome IROS – Insights Research Organization & Solutions as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome IROS – Insights . . .
Read More

Recommendation paper on decentralised elements in clinical trials
Following their meeting on 4 Oct, the EMA/HTAs and EC have published a recommendation . . .
Read More